BioSpace News Archive

TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced that Kate Broderick, Ph.D., has joined the Company as Senior Vice President of Research and Development.

Icosavax, Inc. announced that the company will participate in the William Blair Biotech Focus Conference taking place from July 12-13, 2022, in New York.

The universal Menstrual Cramps Treatment report explains a thorough study of current situation of the global market along with several market dynamics.

Emergent BioSolutions Inc. announced that the company’s board of directors appointed Sujata Dayal as a Class II director to serve on the board effective July 15, 2022, with an initial term expiring at the 2023 annual meeting of stockholders.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2022 financial and operating results on Wednesday, August 3, 2022, before the U.S. financial markets open.

Abata Therapeutics announced that Samantha Singer, M.S., M.B.A., president, and chief executive officer, and John Trzupek, M.B.A., Ph.D., chief operating officer of Abata will participate in a fireside chat at the Guggenheim I&I Spotlight Series – Treg-Based Therapies on Tuesday, July 12, 2022, at 9:35 a.m. ET in New York, NY.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced the Company will disclose its completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis via press release after market close on Tuesday, July 12, 2022.

Data Bridge Market Research Published Latest Global Nasal Spray Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

Breast Imaging Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the Breast Imaging market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years.

Surgalign Holdings, Inc. announced that it has granted restricted stock unit awards to one employee, who was not an executive officer, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 9,259 shares of Surgalign common stock.